Systemic lysis protects against the effects of platelet activation during coronary thrombolysis.
Systemic lysis may protect against the platelet activation and ongoing thrombosis associated with coronary thrombolysis. To address this hypothesis, we compared urokinase and tissue-type plasminogen activator (t-PA) given intravenously in a chronic, canine model of coronary thrombosis. T-PA 10 micro...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1991
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295678/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1939647/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115471 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|